Le centre hospitalier de la Côte Basque est un centre hospitalier français, situé à travers quatre sites principaux sur les communes de Bayonne et Saint-Jean-de-Luz et disposant de sites sur tout le Pays basque français.

During the past decade, Centre Hospitalier de la Côte Basque conducted 124 clinical trials. In the 10-year time frame, 124 clinical trials started and 16 clinical trials were completed, i.e. on average, 12.9% percent of trials that started reached the finish line to date. In the past 5 years, 65 clinical trials started and 11 clinical trials were completed. i.e. 16.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier de la Côte Basque" #1 sponsor was "Groupe Francophone des Myelodysplasies" with 23 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 15 trials sponsored, "The Lymphoma Academic Research Organisation" with 13 trials sponsored, "University Hospital, Bordeaux" with 12 trials sponsored and "Federation Francophone de Cancerologie Digestive" with 12 trials sponsored. Other sponsors include 127 different institutions and companies that sponsored additional 71 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de la Côte Basque" #1 collaborator was "Amgen" with 5 trials as a collaborator, "Celgene" with 5 trials as a collaborator, "Celgene Corporation" with 5 trials as a collaborator, "Janssen-Cilag Ltd." with 4 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 82 different institutions and companies that were collaborators in the rest 73 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de la Côte Basque" are "Multiple Myeloma" (16 trials), "Myelodysplastic Syndromes" (14 trials), "Acute Myeloid Leukemia" (10 trials), "Lymphoma" (6 trials) and "MDS" (6 trials). Many other conditions were trialed in "Centre Hospitalier de la Côte Basque" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de la Côte Basque" are "Drug" (149 trials), "Other" (22 trials), "Procedure" (22 trials), "Biological" (9 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Gemcitabine" (8 trials), "Lenalidomide" (7 trials), "Rituximab" (7 trials) and "Azacitidine" (6 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de la Côte Basque" are 189 trials for "All" genders, 13 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Hospitalier de la Côte Basque". 4 are not yet recruiting, 62 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 105 completed trials in Centre Hospitalier de la Côte Basque, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de la Côte Basque, 9 "Phase 1" clinical trials were conducted, 78 "Phase 2" clinical trials and 70 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 19 trials that are defined as “Not Applicable".

Centre Hospitalier de la Côte Basque has several departments that took part in Clinical trials: "Centre Hospitalier de La Cote Basque; Hematologie" - 11 trials, "Centre Hospitalier de La Cote Basque; Oncologie" - 3 trials